Skip to main content
. 2016 Apr 18;7(18):24983–24994. doi: 10.18632/oncotarget.8804

Figure 2. Adoptive transfer of PHA767491-pretreated CD4+ T cells prolongs skin allograft survival.

Figure 2

A. SCID allogeneic skin transplant recipients received 1×107 PHA767491-pretreated CD4+ T cells (PAT group) at three weeks post-transplantation. Control mice underwent adoptive transfer of PBS-pretreated CD4+ T(CAT group) at three weeks post-transplantation. (n = 5). B. Survival times and conditions of skin allografts. The data are representative of three independent experiments. C. HE staining of skin allografts sections.